EC HPLC column (analytical), NUCLEODUR PFP, 5 µm, 150x4 mm N9300244 Volume 5 µL Syringe Type

Volume 5 µL Syringe Type Gastight Syringe Series 1700 Termination Removable Needle (RN) Needle Small RN Gauge 32 gauge Point Style 3 Needle Length 2 inch (51 mm) Fluid Path SST

1705 50µL HLA (Terasaki) Dispenser  201920 1710 100µL HLA (Terasaki) Dispenser THIS MODEL 201930 1725 250µL HLA (Terasaki) Dispenser 201940 1750 500µL HLA (Terasaki) Dispenser

0–8

H2SO4 and HF matrices should not be a problem depending upon [U]

EC HPLC column (analytical), NUCLEODUR PFP, 5 µm, 150x4 mm N9300244 Volume 5 µL Syringe TypeThis hydrophobic phase with pentafluorophenyl propyl modification is based on high purity NUCLEODUR silica gel and gives an alternative selectivity in comparison to classical C18 modifications. Separation mechanism based on four retention mechanisms polar interactions (H bonds), dipole dipole interactions, interactions and hydrophobic interactions. Suitable for LC MS due to low bleeding characteristics. Technical Data Downloads Brand NUCLEODUR Pore